Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr;111(4):775-82.
doi: 10.1016/j.ophtha.2003.07.013.

Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency

Thomas Reinhard  1 , Helga Spelsberg, Lotte Henke, Theodoros Kontopoulos, Jürgen Enczmann, Peter Wernet, Peter Berschick, Rainer Sundmacher, Daniel Böhringer
Affiliations

Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency

Thomas Reinhard et al. Ophthalmology. 2004 Apr.

Abstract

Objective: To determine the prognosis of allogeneic penetrating limbo-keratoplasty in patients with total limbal stem cell deficiency and to find out if donor limbal stem cells survive in the long run.

Design: Noncomparative prospective case series.

Participants: Forty-eight patients with total limbal stem cell deficiency.

Intervention: Allogeneic penetrating limbo-keratoplasty. All patients received systemic cyclosporin A and/or mycophenolate mofetil in the postoperative course. Thirteen patients received grafts with 0 to 1 HLA mismatches in the HLA-A, HLA-B, and HLA-DR loci; 13 patients received grafts with 2 to 6 mismatches; and 22 patients received untyped grafts.

Main outcome measures: Long-term clear graft survival and survival of donor limbal stem cells.

Results: Five years postoperatively, 65% of the grafts with 0 to 1 mismatches, 41% of the grafts with 2 to 6 mismatches, and 14% of the untyped grafts were clear centrally (estimation according to Kaplan-Meier log rank test, P = 0.03). Immunogenetic analysis of epithelial cells from the surface of the graft could be performed successfully in 7 of 9 patients and revealed donor DNA in the epithelium of 5 of these 7 patients up to 56 months postoperatively.

Conclusions: Long-term survival of donor epithelium could be demonstrated immunogenetically in patients undergoing allogeneic penetrating limbo-keratoplasty. Human leukocyte antigen-matched grafts seem to deliver better results than untyped grafts. Progress with matching and immunosuppressive strategies may further improve current results.

PubMed Disclaimer

MeSH terms